Skip to search formSkip to main contentSkip to account menu

Doxazosin 4 MG Oral Tablet

Known as: DOXAZOSIN MESYLATE 4 mg ORAL TABLET [Doxazosin], DOXAZOSIN MESYLATE 4 mg ORAL TABLET [Doxazosin mesylate], DOXAZOSIN MESYLATE 4MG TAB 
National Institutes of Health

Related topics

Related topics

31 relations
Adrenergic alpha-Antagonists [MoA]Adrenergic alpha1-Antagonists [MoA]Aluminum HydroxideAluminum Oxide

Narrower (1)

Doxazosin 4 MG Oral Tablet [Cardura]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
An open, comparative, multicentre clinical study of combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients with erectile dysfunction and lower urinary tract symptoms…
This study sought to investigate the clinical efficacy and safety of combined oral therapy with sildenafil and doxazosin GITS… 
2004
2004
Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis
An analysis is presented to compare the efficacies of the doxazosin gastrointestinal therapeutic system (doxazosin‐GITS) and… 
Highly Cited
2003
Highly Cited
2003
A randomized, double‐blind crossover study of tamsulosin and controlled‐release doxazosin in patients with benign prostatic hyperplasia
To compare the effects of the doxazosin gastrointestinal therapeutic system, extended‐release (doxazosin‐GITS) formulation, and… 
Review
2003
Review
2003
Effect of Doxazosin GITS on Blood Pressure in Hypertensive and Normotensive Patients: A Review of Hypertension and BPH Studies
Doxazosin is an effective treatment for patients with hypertension, benign prostatic hyperplasia (BPH) and the two comorbidly. In… 
2003
2003
Doxazosin GITS versus hydrochlorothiazide as add‐on therapy in patients with uncontrolled hypertension
The objective of this prospective, randomized, open‐label, parallel‐arm comparative study, with a 4‐month follow‐up, was to… 
Highly Cited
2001
Highly Cited
2001
A combined analysis of double‐blind trials of the efficacy and tolerability of doxazosin‐gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic…
Objective To report an integrated analysis of two previous studies fully characterizing the clinical utility of the controlled… 
2000
2000
Double–Blind Trial of the Efficacy and Tolerability of Doxazosin in the Gastrointestinal Therapeutic System, Doxazosin Standard, and Placebo in Patients with Benign Prostatic Hyperplasia
Background: The α1–blocker doxazosin mesylate is an established efficacious and welltolerated treatment for benign prostatic… 
2000
2000
[Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
BACKGROUND AND METHOD This randomized, doubleblind, multicenter, parallel-group, placebo-baseline study compared the effects of… 
1999
1999
Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
The alpha 1-blocker doxazosin is a well-established therapy for hypertension and benign prostatic hyperplasia; however, in its… 
1999
1999
Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension.
Doxazosin, an effective treatment for mild-to-moderate hypertension and benign prostatic hyperplasia, in its standard formulation… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)